Quick Answer
Xilio Therapeutics, Inc. reported Common Stock Shares Outstanding of 4.53 million shares for the year ending 2025.
- Xilio Therapeutics, Inc. showed an increase of +38.6% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Xilio Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Xilio Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 556.7%.
- Historical annual values: Fiscal year 2025: 4.53 million shares | Fiscal year 2024: 3.27 million shares | Fiscal year 2023: 27.61 million shares | Fiscal year 2022: 27.43 million shares | Fiscal year 2021: 27.36 million shares | Fiscal year 2020: 689,929 shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: